HIV / AIDS
Apr 5, 2023
ICAP conducted an innovative cluster randomized trial aimed at rigorously evaluating the effectiveness of a combination intervention package for the provision of isoniazid preventive therapy (IPT) for tuberculosis in HIV care and treatment programs in Ethiopia, as...
Apr 4, 2023
An innovative and comprehensive approach to HIV prevention and therapeutic research. While much has been achieved in the global response to the HIV epidemic, enormous challenges remain. Only 60% of people living with HIV have access to treatment, and 1.7 million new...
Apr 4, 2023
In September 2002, the Mailman School of Public Health at Columbia University (CU) entered into a Cooperative Agreement with the Centers for Disease Control (CDC) for the University Technical Assistance Projects (UTAP) in Support of the Global HIV/AIDS Program....
Apr 4, 2023
A randomized, active-controlled, double-blind clinical study to investigate the safety and efficacy of oral Islatravir, a once-monthly pill as pre-exposure prophylaxis (PrEP) in cisgender women at high risk for HIV-1 infection. Closed to enrollment. In active study...
Apr 4, 2023
ICAP provided support and technical expertise to the national public health system in the following areas: Supported a national HIV drug resistance survey to assess prevalence and patterns of acquired drug resistance and pre-treatment drug resistance. Supported the...
